ada standards of care 2025 obesity pharmacotherapy glp-1 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee Your Guide to the 2025

Clinical studies have demonstrated its safety and efficacy for long-term weight loss, with patients experiencing significant and sustained weight reduction over a period of up to 68 weeks

By reducing appetite and slowing gastric emptying, these therapies support sustained weight loss and improved longterm metabolic health

8 to 12 weeks: Chronic or degenerative conditions, post-surgical 13 weeks: Severe multi-injury cases Multiple rounds: Conditions that respond partially but do not fully resolve in a single cycle

With the rise in popularity of these medications, Clinical Director of the Alabama Poison Information Center, Jessica Rivera Pescatore says, like with any medications, its important to talk with your doctor about how to take medications properly

Microdose protocols typically begin at 1 mg or 1.25 mg and increase in smaller increments